Cilostazol
Overview
Cilostazol is a phosphodiesterase III inhibitor that suppresses platelet aggregation and is a direct arterial vasodilator used to improve symptoms of intermittent claudication in patients with peripheral vascular disease. It works by inhibiting platelet aggregation and expanding arteries to increase blood flow.
API suppliers (10)
Suppliers of Cilostazol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
6 of 10 hold a GMP certificate on record in the EU or UK registers
- Chongqing Kangle Pharmaceutical Co., Ltd.China2 active DMF
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- Dipharma Francis SrlItaly1 active DMF GMP on record
- WAVELENGTH ENTERPRISES LTDIsrael1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- COHANCE LIFESCIENCES LTDIndia1 active DMF GMP on record
- Ipca Laboratories LimitedIndia GMP on record
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain
- SA AJINOMOTO OMNICHEM NVBelgium
Therapeutic areas
Do you supply Cilostazol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.